URMC Secures $6 Million for Study on Slowing Early Parkinson's
Wednesday, September 2, 2015
Source: Rochester Business Journal
The University of Rochester Medical Center will receive $6 million for a clinical study on slowing early Parkinson’s disease.
It has been has been selected as the coordinating center for data collection in a 60-site clinical investigation of the drug Inosine.
David Oakes, a professor in the Department of Biostatistics and Computational Biology, will facilitate data coordination with study chair Michael Schwarzschild, a neurobiologist at Massachusetts General Hospital. The National Institute of Neurological Disorders and Stroke funded the five-year, $26 million project.